Chondroitin

Chondroitin sulphate is a glycosaminoglycan, a long chain of sugar units, and a major structural component of cartilage. It attracts and holds water, which is what gives cartilage its compressive resilience.

Commercial chondroitin is extracted from animal cartilage, most commonly bovine trachea, with shark and porcine sources also used. Vegetarian versions produced by fermentation exist but are less common.

Product quality is a genuine problem in this category rather than a theoretical concern. Independent testing has repeatedly found products containing substantially less chondroitin than declared, in some cases almost none. It is an expensive raw material, and cheap products are cheap for a reason.

The substrate rationale is that supplying chondroitin supports cartilage maintenance, since it is a building block. As with glucosamine, this logic assumes availability is limiting, which has not been demonstrated.

Chondroitin has also been reported to inhibit enzymes that break down cartilage, and to reduce inflammatory signalling in joint tissue. If it works, this is the more plausible route.

Absorption is a legitimate question. Chondroitin is a very large molecule, and how much reaches joint tissue intact after oral dosing has been debated for years. Molecular weight varies between sources, with lower weight material generally better absorbed.

The evidence follows the same pattern as glucosamine and has been argued over just as long. Some trials report improvements in joint comfort and function; large independent trials have generally found results close to placebo.

Trials using pharmaceutical-grade chondroitin have tended to report better outcomes than those using supplement-grade material, which given the documented quality problems is not surprising and may be part of the explanation.

Evidence that adding chondroitin to glucosamine outperforms glucosamine alone is weak, despite the combination being the standard commercial format. For healthy people using it preventively there is essentially no evidence at all.

Chondroitin is well tolerated across the trial literature. Digestive upset and nausea are the most commonly reported effects and are generally mild.

It is structurally similar to compounds that affect blood clotting, and there is theoretical potential to increase bleeding tendency. Speak to your doctor before use if you take anything affecting clotting, and stop before scheduled surgery.

Animal-derived products raise sourcing questions worth asking about, particularly for bovine material. Shark-derived chondroitin also carries the conservation consideration that some customers will care about.